Search filters

List of works by Mattheos Bobos

A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomas

scientific article published on 5 January 2013

A phase II study of sunitinib in patients with recurrent and/or metastatic non-nasopharyngeal head and neck cancer

scientific article

A randomized phase III study of adjuvant platinum/docetaxel chemotherapy with or without radiation therapy in patients with gastric cancer

scientific article published on 4 February 2010

A rare tumoral combination, synchronous lung adenocarcinoma and mantle cell lymphoma of the pleura

scientific article published on 29 December 2008

Adjusting breast cancer patient prognosis with non-HER2-gene patterns on chromosome 17.

scientific article

Detection of Helicobacter pylori in raw bovine milk by fluorescence in situ hybridization (FISH).

scientific article

Differential response of immunohistochemically defined breast cancer subtypes to anthracycline-based adjuvant chemotherapy with or without paclitaxel

scientific article (publication date: 2012)

EGFR gene gain and PTEN protein expression are favorable prognostic factors in patients with KRAS wild-type metastatic colorectal cancer treated with cetuximab.

scientific article published on 5 March 2014

Eccrine syringofibroadenoma treated with carbon dioxide laser

scientific article published on 13 September 2008

Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.

scientific article published on July 2016

Evaluation of FISH image analysis system on assessing HER2 amplification in breast carcinoma cases

scientific article published on 21 September 2007

Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer.

scientific article published on 19 May 2011

Evaluation of the prognostic role of centromere 17 gain and HER2/topoisomerase II alpha gene status and protein expression in patients with breast cancer treated with anthracycline-containing adjuvant chemotherapy: pooled analysis of two Hellenic Co

scientific article

Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study

scientific article published on 29 May 2015

Expression profiling of 21 biomolecules in locally advanced nasopharyngeal carcinomas of Caucasian patients

scientific article

Gemcitabine combined with gefitinib in patients with inoperable or metastatic pancreatic cancer: a phase II Study of the Hellenic Cooperative Oncology Group with biomarker evaluation

scientific article

HER-2/neu is an independent prognostic factor in type I endometrial adenocarcinoma.

scientific article

HER2 and TOP2A in high-risk early breast cancer patients treated with adjuvant epirubicin-based dose-dense sequential chemotherapy.

scientific article published on 12 January 2012

Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer

scientific article

Immunohistochemical distinction between merkel cell carcinoma and small cell carcinoma of the lung

scientific article published on 01 April 2006

Impact of tumor angiogenic profile on the outcome of patients with metastatic breast carcinoma treated with weekly docetaxel. A Hellenic Cooperative Oncology Group (HeCOG) study

scientific article published on 25 March 2015

In situ detection of hTERT variants in anaplastic large cell lymphoma

scientific article published on 01 August 2006

In situ quantitative measurement of HER2mRNA predicts benefit from trastuzumab-containing chemotherapy in a cohort of metastatic breast cancer patients

scientific article

Induction chemotherapy followed by concomitant radiotherapy and weekly cisplatin versus the same concomitant chemoradiotherapy in patients with nasopharyngeal carcinoma: a randomized phase II study conducted by the Hellenic Cooperative Oncology Grou

scientific article published on 27 April 2011

Intact or broken-apart RNA: an alternative concept for ALK fusion screening in non-small cell lung cancer (NSCLC).

scientific article published in January 2015

Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP cases.

scientific article published on 6 May 2012

Ixabepilone administered weekly or every three weeks in HER2-negative metastatic breast cancer patients; a randomized non-comparative phase II trial

scientific article (publication date: 2013)

MMP9 but Not EGFR, MET, ERCC1, P16, and P-53 Is Associated with Response to Concomitant Radiotherapy, Cetuximab, and Weekly Cisplatin in Patients with Locally Advanced Head and Neck Cancer

scientific article

MYC copy gain, chromosomal instability and PI3K activation as potential markers of unfavourable outcome in trastuzumab-treated patients with metastatic breast cancer

scientific article published on 17 May 2016

Molecular detection of Helicobacter pylori in a large Mediterranean river, by direct viable count fluorescent in situ hybridization (DVC-FISH)

scientific article published on 01 December 2014

PAI-1 and HER2 interaction in advanced breast cancer disease: evidence for added benefit from trastuzumab in HER2-negative patients.

scientific article published on 07 May 2015

Paclitaxel and carboplatin as neoadjuvant chemotherapy in patients with locally advanced breast cancer: A phase II Trial of the Hellenic Cooperative Oncology Group

scientific article published in June 2010

Postoperative dose-dense sequential versus concomitant administration of epirubicin and paclitaxel in patients with node-positive breast cancer: 5-year results of the Hellenic Cooperative Oncology Group HE 10/00 phase III Trial

scientific article published on 21 December 2011

Potential value of PTEN in predicting cetuximab response in colorectal cancer: an exploratory study

scientific article

Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study.

scientific article

Prevalent somatic BRCA1 mutations shape clinically relevant genomic patterns of nasopharyngeal carcinoma in Southeast Europe

scientific article published on 31 August 2017

Profiling immunohistochemical expression of NOTCH1-3, JAGGED1, cMET, and phospho-MAPK in 100 carcinomas of unknown primary.

scientific article

Prognostic and predictive value of p-Akt, EGFR, and p-mTOR in early breast cancer

scientific article

Prognostic significance of ESR1 gene amplification, mRNA/protein expression and functional profiles in high-risk early breast cancer: a translational study of the Hellenic Cooperative Oncology Group (HeCOG)

scientific article

Prognostic significance of RACGAP1 mRNA expression in high-risk early breast cancer: a study in primary tumors of breast cancer patients participating in a randomized Hellenic Cooperative Oncology Group trial.

scientific article

Prognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary

scientific article published on 13 August 2015

Prognostic significance of the Wnt pathway in squamous cell laryngeal cancer

scientific article published on 21 January 2014

Prognostic utility of β-tubulin isotype III and correlations with other molecular and clinicopathological variables in patients with early breast cancer: a translational Hellenic Cooperative Oncology Group (HeCOG) study.

scientific article

Sarcoidosis-like granulomatosis of the hypopharynx as a complication of anti-TNF therapy

scientific article published on 26 January 2013

Screening for EGFR Mutations in Patients with Head and Neck Cancer Treated with Gefitinib on a Compassionate-Use Program: A Hellenic Cooperative Oncology Group Study

scientific article

Sialadenoma papilliferum of bronchus

scientific article published on 21 August 2003

TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting

scientific article published on 26 April 2016

The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping

scientific article published on 3 April 2014

Topoisomerase I but not thymidylate synthase is associated with improved outcome in patients with resected colorectal cancer treated with irinotecan containing adjuvant chemotherapy

scientific article

Topoisomerase II alpha gene amplification is a favorable prognostic factor in patients with HER2-positive metastatic breast cancer treated with trastuzumab.

scientific article

Trastuzumab combined with pegylated liposomal doxorubicin in patients with metastatic breast cancer. phase II Study of the Hellenic Cooperative Oncology Group (HeCOG) with biomarker evaluation.

scientific article published on 05 March 2009

Triple-negative phenotype is of adverse prognostic value in patients treated with dose-dense sequential adjuvant chemotherapy: a translational research analysis in the context of a Hellenic Cooperative Oncology Group (HeCOG) randomized phase III tri

scientific article

Tubular Pyloric Gland Adenoma of the Left and Right Hepatic Ducts: Report of a Unique Case With Immunohistochemical and Molecular Studies.

scientific article published on 13 January 2016

[Simultaneous existence of unicameral bone cysts involving the femur and ischium]

scientific article published on 01 March 2009

alphaB-crystallin is a marker of aggressive breast cancer behavior but does not independently predict for patient outcome: a combined analysis of two randomized studies.

scientific article

p85 protein expression is associated with poor survival in HER2-positive patients with advanced breast cancer treated with trastuzumab.

scientific article published on 8 August 2014